[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
:: Volume 6 - The Spring Supplement of Shefaye Khatam 1 - ::
Shefaye Khatam 2018, 6 - The Spring Supplement of Shefaye Khatam 1 -: 25-25 Back to browse issues page
O25: Treatment of Autoimmune Epilepsy
Mohammad Taghi Farzadfard *
Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran , farzadfardmt@mums.ac.ir
Abstract:   (37 Views)

Seizure and epilepsy can be related to autoimmune diseases and processes. Accurate diagnosis is essential for better treatment of these conditions. Different clinical studies have been conducted to diagnose and treat autoimmune epilepsy. Rapid treatment of these diseases helps to Improve prognosis and less relapses. Conventional epilepsy treatments including antiepileptic drugs are less successful in these cases. Early first line immunotherapy (corticosteroids, intravenous immunoglobulin, plasma exchange) provides fair response to autoimmune encephalitides but half or more patients require a second-line immunotherapy. (Rituximab, Cyclophosphamide). A significant percentage of patients are resistant to first and second line immunotherapy and require further treatment.

Keywords: Autoimmune Epilepsy, Treatment, Immunotherapy
Full-Text [PDF 228 kb]   (16 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farzadfard M T. O25: Treatment of Autoimmune Epilepsy. Shefaye Khatam. 2018; 6 (S1) :25-25
URL: http://shefayekhatam.ir/article-1-1553-en.html


Volume 6 - The Spring Supplement of Shefaye Khatam 1 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 31 queries by YEKTAWEB 3647